Philip Coetzee

This year’s conference will delve into the strategic business imperatives for fostering robust collaborations between CMOs and pharmaceutical companies in an ever evolving and uncertain landscape.

Join this session to explore the growing trend of pharmaceutical companies acquiring contract manufacturing sites. We will delve into the motivations behind these acquisitions and their potential implications for the broader contract manufacturing landscape, and the challenges and opportunities that arise from this strategy.

This concluding session will provide a comprehensive summary of the key learnings and takeaways from the first day of the conference. By revisiting the most impactful presentations, discussions, and networking opportunities, attendees will gain a deeper understanding of the industry trends, challenges, and solutions presented throughout the day